Restoration of vasodilation and CBF autoregulation by genistein in rat pial artery after brain injury

Am J Physiol Heart Circ Physiol. 2001 Jul;281(1):H308-15. doi: 10.1152/ajpheart.2001.281.1.H308.

Abstract

This study determined whether, after fluid percussion injury (FPI), tyrosine kinase activation is coupled to inhibition of K(+) channels and alteration in cerebral blood flow (CBF) autoregulation in the rat pial artery. Injury of moderate severity (2--2.5 atm) was produced by FPI in anesthetized rats equipped with a closed cranial window. The suppressed vasodilation of the pial arterioles to calcitonin gene-related peptide (CGRP) and levcromakalim (LMK) and altered lower limit of CBF autoregulation after FPI were restored by genistein but not by daidzein, an inactive analog. Vasodilation to S-nitroso-N-acetyl penicillamine (0.1--10 micromol/l) was, however, little influenced after FPI. The restored vasodilation was decreased by sodium orthovanadate, suggesting the reciprocal action of tyrosine phosphorylation and dephosphorylation. After FPI, CGRP-induced vasodilation restored by genistein (10 micromol/l) was strongly antagonized by iberiotoxin but not by glibenclamide, whereas LMK-induced vasodilation was, in contrast, inhibited by glibenclamide but not by iberiotoxin. Taken together, we suggest that, after FPI, activation of tyrosine kinase links the inhibition of K(+) channels to impaired autoregulatory vasodilation in response to acute hypotension and alteration in CBF autoregulation in the rat pial artery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arteries / drug effects
  • Arteries / physiopathology
  • Brain Injuries / physiopathology*
  • Calcitonin Gene-Related Peptide / pharmacology
  • Cerebrovascular Circulation / drug effects*
  • Cromakalim / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Genistein / pharmacology*
  • Homeostasis*
  • Male
  • Penicillamine / analogs & derivatives
  • Penicillamine / pharmacology
  • Pia Mater / blood supply*
  • Potassium Channel Blockers
  • Protein Tyrosine Phosphatases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Rats
  • Rats, Sprague-Dawley
  • S-Nitroso-N-Acetylpenicillamine
  • Vasodilation*
  • Vasodilator Agents / pharmacology

Substances

  • Enzyme Inhibitors
  • Potassium Channel Blockers
  • Vasodilator Agents
  • Cromakalim
  • S-Nitroso-N-Acetylpenicillamine
  • Genistein
  • Protein-Tyrosine Kinases
  • Protein Tyrosine Phosphatases
  • Penicillamine
  • Calcitonin Gene-Related Peptide